text:
import { browserTest as it, expect } from '../config/browserTest';

it('should intercept', async ({ browser, server }) => {
  const context = await browser.newContext();
  let intercepted = false;
  await context.route('**/empty.html', route => {
    intercepted = true;
    const request = route.request();
    expect(request.url()).toContain('empty.html');
    expect(request.headers()['user-agent']).toBeTruthy();
    expect(request.method()).toBe('GET');
    expect(request.postData()).toBe(null);
    expect(request.isNavigationRequest()).toBe(true);
    expect(request.resourceType()).toBe('document');
    expect(request.frame() === page.mainFrame()).toBe(true);
    expect(request.frame().url()).toBe('about:blank');
    route.continue();
  });
  const page = await context.newPage();
  const response = await page.goto(server.EMPTY_PAGE);
  expect(response.ok()).toBe(true);
  expect(intercepted).toBe(true);
  await context.close();
});

it('should unroute', async ({ browser, server }) => {
  const context = await browser.newContext();
  const page = await context.newPage();

  let intercepted = [];
  await context.route('**/*', route => {
    intercepted.push(1);
    route.fallback();
  });
  await context.route('**/empty.html', route => {
    intercepted.push(2);
    route.fallback();
  });
  await context.route('**/empty.html', route => {
    intercepted.push(3);
    route.fallback();
  });
  const handler4 = route => {
    intercepted.push(4);
    route.fallback();
  };
  await context.route('**/empty.html', handler4);
  await page.goto(server.EMPTY_PAGE);
  expect(intercepted).toEqual([4, 3, 2, 1]);

  intercepted = [];
  await context.unroute('**/empty.html', handler4);
  await page.goto(server.EMPTY_PAGE);
  expect(intercepted).toEqual([3, 2, 1]);

  intercepted = [];
  await context.unroute('**/empty.html');
  await page.goto(server.EMPTY_PAGE);
  expect(intercepted).toEqual([1]);

  await context.close();
});

it('should yield to page.route', async ({ browser, server }) => {
  const context = await browser.newContext();
  await context.route('**/empty.html', route => {
    route.fulfill({ status: 200, body: 'context' });
  });
  const page = await context.newPage();
  await page.route('**/empty.html', route => {
    route.fulfill({ status: 200, body: 'page' });
  });
  const response = await page.goto(server.EMPTY_PAGE);
  expect(response.ok()).toBe(true);
  expect(await response.text()).toBe('page');
  await context.close();
});

it('should fall back to context.route', async ({ browser, server }) => {
  const context = await browser.newContext();
  await context.route('**/empty.html', route => {
    route.fulfill({ status: 200, body: 'context' });
  });
  const page = await context.newPage();
  await page.route('**/non-empty.html', route => {
    route.fulfill({ status: 200, body: 'page' });
  });
  const response = await page.goto(server.EMPTY_PAGE);
  expect(response.ok()).toBe(true);
  expect(await response.text()).toBe('context');
  await context.close();
});

it('should support Set-Cookie header', async ({ contextFactory, server, browserName, defaultSameSiteCookieValue }) => {
  it.fixme(browserName === 'webkit');

  const context = await contextFactory();
  const page = await context.newPage();
  await page.route('https://example.com/', (route, request) => {
    route.fulfill({
      headers: {
        'Set-Cookie': 'name=value; domain=.example.com; Path=/'
      },
      contentType: 'text/html',
      body: 'done'
    });
  });
  await page.goto('https://example.com');
  expect(await context.cookies()).toEqual([{
    sameSite: defaultSameSiteCookieValue,
    name: 'name',
    value: 'value',
    domain: '.example.com',
    path: '/',
    expires: -1,
    httpOnly: false,
    secure: false
  }]);
});

it('should ignore secure Set-Cookie header for insecure requests', async ({ contextFactory, server, browserName }) => {
  it.fixme(browserName === 'webkit');

  const context = await contextFactory();
  const page = await context.newPage();
  await page.route('http://example.com/', (route, request) => {
    route.fulfill({
      headers: {
        'Set-Cookie': 'name=value; domain=.example.com; Path=/; Secure'
      },
      contentType: 'text/html',
      body: 'done'
    });
  });
  await page.goto('http://example.com');
  expect(await context.cookies()).toEqual([]);
});

it('should use Set-Cookie header in future requests', async ({ contextFactory, server, browserName, defaultSameSiteCookieValue }) => {
  it.fixme(browserName === 'webkit');

  const context = await contextFactory();
  const page = await context.newPage();

  await page.route(server.EMPTY_PAGE, (route, request) => {
    route.fulfill({
      headers: {
        'Set-Cookie': 'name=value'
      },
      contentType: 'text/html',
      body: 'done'
    });
  });
  await page.goto(server.EMPTY_PAGE);
  expect(await context.cookies()).toEqual([{
    sameSite: defaultSameSiteCookieValue,
    name: 'name',
    value: 'value',
    domain: 'localhost',
    path: '/',
    expires: -1,
    httpOnly: false,
    secure: false
  }]);

  let cookie = '';
  server.setRoute('/foo.html', (req, res) => {
    cookie = req.headers.cookie;
    res.end();
  });
  await page.goto(server.PREFIX + '/foo.html');
  expect(cookie).toBe('name=value');
});

it('should work with ignoreHTTPSErrors', async ({ browser, httpsServer }) => {
  const context = await browser.newContext({ ignoreHTTPSErrors: true });
  const page = await context.newPage();

  await page.route('**/*', route => route.continue());
  const response = await page.goto(httpsServer.EMPTY_PAGE);
  expect(response.status()).toBe(200);
  await context.close();
});

it('should support the times parameter with route matching', async ({ context, page, server }) => {
  const intercepted = [];
  await context.route('**/empty.html', route => {
    intercepted.push(1);
    route.continue();
  }, { times: 1 });
  await page.goto(server.EMPTY_PAGE);
  await page.goto(server.EMPTY_PAGE);
  await page.goto(server.EMPTY_PAGE);
  expect(intercepted).toHaveLength(1);
});

it('should support async handler w/ times', async ({ context, page, server }) => {
  await context.route('**/empty.html', async route => {
    await new Promise(f => setTimeout(f, 100));
    route.fulfill({
      body: '<html>intercepted</html>',
      contentType: 'text/html'
    });
  }, { times: 1 });
  await page.goto(server.EMPTY_PAGE);
  await expect(page.locator('body')).toHaveText('intercepted');
  await page.goto(server.EMPTY_PAGE);
  await expect(page.locator('body')).not.toHaveText('intercepted');
});

it('should overwrite post body with empty string', async ({ context, server, page, browserName }) => {
  await context.route('**/empty.html', route => {
    route.continue({
      postData: '',
    });
  });

  const [req] = await Promise.all([
    server.waitForRequest('/empty.html'),
    page.setContent(`
      <script>
        (async () => {
            await fetch('${server.EMPTY_PAGE}', {
              method: 'POST',
              body: 'original',
            });
        })()
      </script>
    `),
  ]);

  const body = (await req.postBody).toString();
  expect(body).toBe('');
});

it('should chain fallback', async ({ context, page, server }) => {
  const intercepted = [];
  await context.route('**/empty.html', route => {
    intercepted.push(1);
    route.fallback();
  });
  await context.route('**/empty.html', route => {
    intercepted.push(2);
    route.fallback();
  });
  await context.route('**/empty.html', route => {
    intercepted.push(3);
    route.fallback();
  });
  await page.goto(server.EMPTY_PAGE);
  expect(intercepted).toEqual([3, 2, 1]);
});

it('should chain fallback w/ dynamic URL', async ({ context, page, server }) => {
  const intercepted = [];
  await context.route('**/bar', route => {
    intercepted.push(1);
    route.fallback({ url: server.EMPTY_PAGE });
  });
  await context.route('**/foo', route => {
    intercepted.push(2);
    route.fallback({ url: 'http://localhost/bar' });
  });

  await context.route('**/empty.html', route => {
    intercepted.push(3);
    route.fallback({ url: 'http://localhost/foo' });
  });

  await page.goto(server.EMPTY_PAGE);
  expect(intercepted).toEqual([3, 2, 1]);
});

it('should not chain fulfill', async ({ context, page, server }) => {
  let failed = false;
  await context.route('**/empty.html', route => {
    failed = true;
  });
  await context.route('**/empty.html', route => {
    route.fulfill({ status: 200, body: 'fulfilled' });
  });
  await context.route('**/empty.html', route => {
    route.fallback();
  });
  const response = await page.goto(server.EMPTY_PAGE);
  const body = await response.body();
  expect(body.toString()).toEqual('fulfilled');
  expect(failed).toBeFalsy();
});

it('should not chain abort', async ({ context, page, server }) => {
  let failed = false;
  await context.route('**/empty.html', route => {
    failed = true;
  });
  await context.route('**/empty.html', route => {
    route.abort();
  });
  await context.route('**/empty.html', route => {
    route.fallback();
  });
  const e = await page.goto(server.EMPTY_PAGE).catch(e => e);
  expect(e).toBeTruthy();
  expect(failed).toBeFalsy();
});

it('should chain fallback into page', async ({ context, page, server }) => {
  const intercepted = [];
  await context.route('**/empty.html', route => {
    intercepted.push(1);
    route.fallback();
  });
  await context.route('**/empty.html', route => {
    intercepted.push(2);
    route.fallback();
  });
  await context.route('**/empty.html', route => {
    intercepted.push(3);
    route.fallback();
  });
  await page.route('**/empty.html', route => {
    intercepted.push(4);
    route.fallback();
  });
  await page.route('**/empty.html', route => {
    intercepted.push(5);
    route.fallback();
  });
  await page.route('**/empty.html', route => {
    intercepted.push(6);
    route.fallback();
  });
  await page.goto(server.EMPTY_PAGE);
  expect(intercepted).toEqual([6, 5, 4, 3, 2, 1]);
});

it('should fall back async', async ({ page, context, server }) => {
  const intercepted = [];
  await context.route('**/empty.html', async route => {
    intercepted.push(1);
    await new Promise(r => setTimeout(r, 100));
    route.fallback();
  });
  await context.route('**/empty.html', async route => {
    intercepted.push(2);
    await new Promise(r => setTimeout(r, 100));
    route.fallback();
  });
  await context.route('**/empty.html', async route => {
    intercepted.push(3);
    await new Promise(r => setTimeout(r, 100));
    route.fallback();
  });
  await page.goto(server.EMPTY_PAGE);
  expect(intercepted).toEqual([3, 2, 1]);
});


text:
Summerfest Sessions with SaraBeth
A Stage for Dreamers
Musicians around the world dream of landing a gig at a music festival. And because of our partnership with Summerfest — the world's largest music festival — we're committed to helping these up and coming artists make their dreams a reality.
In 2018, we invited country music singer, SaraBeth, to play a set to the American Family Insurance House at Summerfest in Milwaukee. With her partner, Glen, their performance packed the house and with it, validated all the hard work that helped her fulfill her dream.
"[Playing at Summerfest] is one of those affirmation steps, if that makes sense — like I can do this, I'm here," said SaraBeth. "It's a crazy dream, it's a hard dream, and it's taken 6 years. It's a festival that everyone plays and to be here is a really cool thing."
SaraBeth's Story
SaraBeth Swagerty's love of music was always present — whether it was Christmas carols or singing along to her great grandma's Patsy Cline cassette tapes. But despite her passion for music, she wasn't always confident in her singing ability.
"There was a moment where I really had some self-doubt and I thought 'I can't do this,'" says SaraBeth. "Anytime you uproot your entire life…to actually take that step was the first time I was actually like, 'Alright, I'm going to give this 100% and I'm just going to do the best I can."
After a moving to Nashville six years ago, SaraBeth has been working hard to make her dream a reality. She's built an established fan base, scored two nationally charted singles, and toured across the UK – but it's not without its challenges. She credits her persistence for getting her to where she is today.
"The biggest obstacle for musicians is that you're told 'no' a lot," says SaraBeth. "You just have to go back and fight and work harder and continue to improve your craft and eventually you'll get to where you want to be."
But with all her achievements during her years on the road, SaraBeth still has yet to cross one item off her bucket list — playing at the largest music festival in the world.
"I've never played Summerfest — it's one of those pinnacle things," says SaraBeth. "I want to get there, I want to play there, I want to see the fans."
And when we heard her story, we knew we could help with that.
We invited SaraBeth to the American Family Insurance House at Summerfest in Milwaukee to help her fulfill her dream. With her partner, Glen, their performance packed the house and with it, validated all the hard work that helped get her to that point.
But a gig at Summerfest is just the beginning of a new chapter in SaraBeth's dream. She's continuing to put out new music, connect with her fans, because in the end, it's the music that drives her.
"I'm really ready…to just continue doing what I love to do."
Related Topics: Community , Passions
7 Tips for Setting Career Goals & 9 Examples
Looking to take the next big step in your career? Learn how to effectively set up your career goals (with examples) & set yourself up for professional success.
Goal vs Objective: What's the Difference & Examples
"Goal" and "objective" may often be inaccurately used interchangeably, but knowing their differences is critical when planning and defining your map to success.
Setting Long-term Goals: 30 Examples
Long-term goals are crucial for planning a successful future. Learn about the definition of a long-term goal along with examples and tips to create them.
SMART Goals: How Do People Set Goals for Themselves?
What are SMART goals? How do they work? How do people set achievable goals for themselves? Learn more about how SMART goal setting will help you achieve success.

redpajama_set_name: RedPajamaCommonCrawl


21 year old testosterone level of 267 ng/dl and bone density z score of -2.6 for spine. Are there any treatment options?
28 w osteoporosis and spinal fractures low vit d is all that was found! Is this what caused it? And can it be reversed if i take my vit d?
41, myastheniaGravis, osteoporosis from 15yr pred! Endo says 100%chance if fall hip/spine break. HOW do I control weak muscles & bones & anxiety?
48 yr old female with osteoporosis, taking calcium and D: What is the best exercise regimen for me to strengthen hip and back bone and muscle?
50k vit d weekly x 8 weeks for defiency & slow healing stress reaction. I'm prone to bone spurs. Is it likely spurs will grow or increase with added d?
50year old male had L1comprassion bone fracture .whith history of osteoprosis what. is the best recomended treatment and the cost in Amirca?
A recent hand X-ray noted "demineralization." I have osteoporosis from 20 years of depakote. Are the demineralization and osteoporosis related?
A study showed that n saids or any anti inflammatories inhibit, or prevent bone growth. Is this true?
After a cervical d&fusion, how much extra calcium & vit d is good for helping optimize bone growth?
Any advice? What tests are required before taking evista (raloxifene)?
Any treatment besides calcium for osteopenia or do you need to wait till osteoporosis?
Are there any pills that you can prescribe to strengthen weak bones?
Are there any studies on the effects of pot use and bone healing?
Are there many women who after ooph and meds develop severe osteoporosis and shouldnt they be monitored?
Been on Forteo for 16 months.have a 5.45 TSH. Have had several odd bone spurs develop and discontinued the Forteo injections. Any reason for concern?
Best way to treat osteopenenia for a 73yo?
Bone density in hips severe, take Crestor (rosuvastatin) for high cholesterol, mother stroke at 77. Dr. Recommends Evista, so many scary side effects. Yes or no?
Breast cancer, bone mets. Doctors cancelled mom's zometa therapy due to continuously low calcium. Can they increase ca just prior infusion and after?
Can anyone strathen their neck 31 year old male with osteoporosis in all my bones ?
Can bilateral oopherectomy cause someone to have osteoporosis and is there a way to stop it from worsening?
Can chest rickets be corrected at the age of 17 without operation . How to improve calcium &vitamin d if I have chest rickets?
Can I counteract potential osteoporosis family history by taking calcium supplements?
Can I stop bone density loss if it is caused by my prescription medications?
Can I stop bone density loss if it is caused by prescribed medication?
Can i take caltrate to help in my avnecrosis?
Can osteo bi-flex with 5-loxin advanced triple strength cause an increase in blood pressure ?
Can osteoporosis of the feet be cured at age 67 in a female?
Can severe osteoporosis and arthritis come from the same root cause or are they both independent of each other?
Can side effect from zometa be so great that it should be cancelled, esp low calcium? (breast cancer, extensive bone mets) thank you.
Can you take calcium after calcification of fractured leg?
Can you take calcium supplements for initial osteopenia with a heart disease that's usually treated also with calcium-channel blockers (but not mine)?
Can you tell me how could vitamin d help to maintain strong bones helping to prevent the development of osteoporosis?
Could chiropractic adjustments be unsafe if I have low bone density?
Dexa normal til 2 yrs ago, then doc said I have osteopenia. I was concerned but she laughed at me, saying it just means thin bone. Should i take med?
Diagnosed w/osteoporosis and spinal fractures high risk for more fractures is there anything i can do to gain bone mass w/out scary meds like fosamax (alendronate)?
Do I need to stop taking calcium supplement before full body bone scan?
Does severe osteoporosis affect the heels?
Does taking glucosamine chondroitin help to fortify bone density in elderly people?
Does taking weight gaining capsules/tablets continously for two years or so cause avascular necrosis of hips or other joints ? I m having it. Plz say.
Dr happy with alendronate 70mg & ca -d supplement for severe osteopenia (t-2.3) in spine. Would strontium citrate supplement be helpful too?
During the first year after oopherectomy and taking arimidex, (anastrozole) what amount of bone loss can I expect if not on any treatment to prevent loss?
Elderly mother has a small fracture in her back. How is that treated? What is the best treatment for osteoporosis?
For 57+ F with stage-2 osteoarthritis of knee joints, which one is better - Uniflexin tablets or Collagen Peptide along with calcium & vitD medicines?
Fosamax, Vitamin d & calcium for 9 mths now. My Yearly Dexa showed last yr -3.6. Now -3.4 only. Is it even worth being "happy" with results??
GNC multivitamin warns to stop taking at least 2 weeks prior to surgery. Does this include dental such as extraction & bone graft? how about after?
Has anybody tried bisphosphonates to treat osteoporosis?
Have 2 ribs fractured as result of a cough.Is vitamine d and calcium supp a good option for healing?
Have long span final fusion with loosening hardware, told I have osteoporosis, dr. Wants me to go on forteo before he tries to do corrective sx, safe?
Have problem associated with tests for osteoporosis==no money to pay. Cant I just take calcium?
Hi dr i want to ask you there is osteoporosis after pregnancy? And its temporarily?
Hi I am 60 yrs old weigh 119 pds I have peni not osteoporosis i go for all my doctors every year I do have density in brest. Can evista (raloxifene) help that?
Hi. I have osteoporotic bones due to steroid treatment and wanted to try chiropractic for regaining function after a fall. Would this be a safe option?
How can vitamin d help to maintain strong bones helping to prevent the development of osteoporosis?
How do I know bone meds are working, without having to wait 2 more yrs for nxt dexa. I cannot afford to lose anymore density.
How does lupus effect a broken radius in elderly?
How does phosphate binder cause hpercalcemia ? And why it is more severe in patients with low-turnover bone disease ?
How is steroid-induced osteoporosis (siop) treated?
How long does it take for a bisophanate to give protection from fractures in relation to osteoporosis (severe)?
How long does it take for bone density to weaken if unable to exercise for 2 months? Eat healthy, no meds. Have mild osteopenia.
How long should fosomax be taken? When should a bone scan be done after starting fosomax?
How long should it take to see bone growth on a three level fusion for an otherwise healthy 29yo? Electromagnetic stimulator used. Is 5mth too soon???
How much is vertebral fracture risk reduction with using estrogen?
How often should someone with osteopenia get a dexascan?
How safe is fosama to take if you have already had a hip fracture?
How we can treat patient with osteoporosis if blood calcium is normal ?
How will pregnancy affect my bones if I don't get much calcium?
I am 23 and have osteoporosis and osteopenia due to an eating disorder and steroid use(for CAH) what can I take other than vitamins to correct ?
I am 42, premenopausal and have osteopenia. Is it possible for me to reverse the osteopenia, perhaps by training with weights?
I am a 46 yr. Old female, 7 yrs. Post-hyst. Should i continue the caltrate supplements after healing my broken leg?
I am a healthy 53 yo and wonder if a bone mass screening is needed. I am post menopausal.?
I am I my 20s but I am diagnosed with osteopenia ,do I need medications? What is the risk and benefits?
I am on strontium ranelate 7mths but due to see a different dr, if he changes meds, is it safe to do so immediately or do I need a break?
I am on strontium ranelate for severe osteoporosis, how long does it take to stop bone loss, and how long before i start to build new bone. ?
I believe i can feel my severe osteoporosis in my spine, my doctor says you cannot feel osteoporosis, which is true?
I can feel tingling in my shin bones, my doctor thinks this is rubbish, I am on strontium ranelate and have severe osteoporosis.
I can't take vitamin d & calcium due to sarcoid, I have compression fracture in spine what can I do to make bones strong?
I don't see any information about treating brittle bone with a supplement of collagen, could that help, I have a 3 year old recently diagnosed.?


Today, November 18, the EuroCloud Slovakia holds its EuroCloud Day.
Árpád Geréd, as a representative of EuroCloud.Austria, will speak on the most current legal challenges related to Cloud Computing and will also provide an insight into the current state of the standardization project at the ETSI, which has been initiated by the EU.
Further speakers are Katarina Nevedalova (Member of the European Parliament), Peter Weber (ITAS) as well as representatives of renowned IT-companies.


Update: Apple tells TechCrunch that the feature we saw should roll out to users over the next few weeks.
Apple appears to be testing a new feature for the iOS version of the App Store that presents users with related search terms at the top of the search results page.
The feature isn't available to everyone yet, but users on iOS 7.1 and 7.0.x are reporting spotting it. 9to5Mac's own Zac Hall only had access to the feature temporarily, though his search results have now returned to the previous design.
Tapping the suggestions at the top of the page takes users to a new search page for that term, which, as pointed out by Osadcha, results in even more suggestions.
There's no word on when (or if) this experimental feature will be rolled out to all users, but it looks like it will be pushed out over-the-air without the need for a full iOS update. Apple has made small changes to the App Store interface without a full update before—a feature that's possible because the App Store (and iTunes Store) pull a large part of their interfaces from the Internet rather than including them within the apps.


The Portable Clothing, Garment and Fabric Steamer from Pyle Home features an angled spout. Operation is safe and free of hassle. The streamer uses tap water, so no chemicals or cleanings solutions need to be involved.


text:
Small Talk with Nitiya Walker
Photo: Winnie Au
Nitiya Walker '14
In high school, a friend's mother taught Nitiya Walker '14 a strategy for filling out award applications. The advice helped Walker win a Women of Distinction award from the Girl Scouts and a Posse Foundation scholarship to Babson. Wanting to share this knowledge with others, Walker founded Seeds of Fortune, which helps minority women in New York City apply for college scholarships. Three girls attended the inaugural program, which Walker launched the summer before her senior year at Babson. Since then, she has added career and financial management skills to the nonprofit's offerings and developed plans to extend the program nationally. Now about 30 girls are in the program, and its class of 2016 earned more than $1 million in scholarships and grants.
Where did you grow up? I grew up in Brooklyn. In the '90s, Brooklyn had a lot of creativity and small-business owners. My dad owned a black theater in Manhattan, so I was there a lot. It was called the Ujamaa Black Theater. It put on dramatic plays, written and directed by my father, that told the black experience. I was in some of them.
Why come to Babson? I was a vocal major in high school, but I always loved business and entrepreneurship, too. I realized that either I would become Beyonce or do something else, and I knew I didn't want to be a starving artist. I experimented with candy selling when I was in high school and made $1,000 a month.
What would be your dream job? I love the entertainment industry, so I work in marketing for Viacom. I really enjoy integrated marketing and would like to see where that journey takes me. But some day, maybe in my 40s, I think I'd like to work for the White House Council on Women and Girls. I learned about it when I was invited to the White House's United State of Women Summit this June. About 5,000 women doing amazing things in their respective fields were invited. Oprah interviewed Michelle Obama about trailblazing the path for women. Every woman I ever wanted to meet was there.
A summit take-away? One idea can have an impact and change lives if you have the tenacity to stand up and be the leader.
A favorite entertainer? Maybe Kanye West. I know a lot of people think he's a crazy man. But as outlandish as his vision is at times, the fact that he has the capacity to dream big and bold and doesn't care about opinions and doesn't let them deter him—that kind of confidence breeds success.—Donna Coco
Embracing Diversity of All Kinds
Students from across the country and around the world, from different backgrounds and cultures, live and learn side by side at Babson. This multitude …
Ready to Launch
Women entrepreneurs may face unique challenges, but one thing can put them ahead of the pack: a business education that stresses entrepreneurship and …


Download Free COMPUTER Games,Download Taking pictures Games,Obtain Journey Games,Download Wrestling Games,Obtain GTA Games and Download Action Games. We are going to at all times exit of our method to source the product you might be on the lookout for. The Sport Monkey and his workforce of skilled Chimps have been working laborious providing people with gaming bargains since 2006. Artifacts of the Past – Ancient Mysteries. There may be a lot of content that wants unlocking, and also you get to choose from an arsenal of a few of the best vehicles as well. Though the game is free on both App Retailer, and Google Play store, the game has in-app purchases that you are free to disregard.


Aging while Black is an act of survival.
The story of Africans in America is a story of continuous systematic efforts to bring about our subjugation and demise, but magically we thrive. Against great efforts to hold us back, as a people we are no more near our end than the end of all things. But as we work to shape our futures, we must be aware of deep-rooted anti-aging messages and the ways that they shape our community. While old age and death are linked in the dominant American consciousness, too often for African-Americans, age does not predict when death will come knocking.
We have seen death take our babies, our youth, our middle-aged folks and our elders. Death by police firearms, death due to lack of healthcare, death from drinking polluted water. So, what does it mean to age as a Black person in America? When incarceration and murder steal the lives of thousands of Black men and boys under the age of 30 each year, how do we make sense of life at later ages? How do we reconcile the dominant white cultural denigration of aging with the reverence that many African-Americans have for their family and community elders?
There is no Black future without Black youth and Black elders working together in solidarity.
We can settle these incongruences by fostering a mentality centered in Black sustainability and in an appreciation for the revolutions of the aging process. Because the stress of being an African in America is literally producing greater wear on our internal organs than those of other ethnic groups, making us more susceptible to heart disease, stroke, disabilities, and other chronic illnesses, African-Americans cannot afford to be concerned with superficial aspects of aging like wrinkles and sagging skin..
The "Black don't crack" mantra is one that Black folks have proudly exclaimed for years, but the expression belies latent ageism and internalized sexism that correlates aging with a descent from desirability and attractiveness. The pressures that come along with being a "strong Black woman" who maintains a household, works outside of the home, and retains youthful features come at a major cost to Black women's health – a cost whose only return is the reaffirmation of dominant white standards of beauty that exclude Black women.
Negative stereotypes about aging can also be found in modern Black resistance struggles. On one side, young activists have made claims of "reverse ageism," elders perceive younger generations as foolish and inexperienced. On another side, some elders believe that young activists have failed to seek the mentorship of older folks or to be guided by freedom traditions of the past. As a result, a divisive battle of wills centered on age stifles Black progress.
The eradication of ageism is important for thriving Black lives and free Black futures.
However, the distance in years between these groups does not necessarily equate to a distance in goals. As freedom fighters, we must work together because there is no Black future without Black youth and Black elders working together in solidarity.
In fact, we can already see some of the fruits of intergenerational and intersectional Black activism in the 21st century. Resistance movements like Black Lives Matter has shown us that leadership is not dependent on age. While it may be important to give age-specific groups space to gather and commune, we should always ensure that there is also space for the contributions of folks of all ages.
Some argue that ageism is the least likely of all the "isms" to be seriously challenged in social contexts, but its eradication is important for thriving Black lives and free Black futures.


One of the most important components to insure the survival or newly planted trees, transplanted trees and established trees is proper watering. Drought conditions will weaken and stress trees, resulting in stunted shoot growth, sparse foliage and higher susceptibility to insects and diseases. A watering schedule should be followed to insure the tree is receiving accurate amount of water.
Proper watering is the most important component in the care of a transplanted tree. Too much or too little water can result in tree injury. Newly planted trees and shrubs may need to be watered for two to three years until their root systems become established. Large trees that have been transplanted may take longer.
For the first few months of the growing season after a tree is planted the tree draws most of its moisture from the root ball. The root ball can dry out in only a day or two, therefore it is critical to apply the water to the root ball area of the tree by either a soaker hose system or using a hose with the water rate at an extremely slow rate (to avoid runoff) and by the moving the hose periodically. The ideal amount of water per week should be in the 1-inch volume.
The City of Geneva would greatly appreciate if resident's who have received a newly planted tree in the parkway in front of their residence, would provide weekly watering to insure the survival of the young trees.
Even after trees are well established, they should be watered generously during periods of drought. The top 8-12 inches of the soil should be kept moist around trees during periods of drought, at least as far as the branches spread (drip line).
It is impossible to provide a formula on how much or how often to water a tree to keep the upper 8-12 inches of soil moist. The amount of water required will vary with local site conditions, but without adequate rainfall, established trees may need watering as often as every 10-14 days or 1 inch weekly. A soaker hose system or using a hose with an extremely low water rate can be used.
If the ground is level, simply let an open hose run on the ground at an extremely slow water rate (avoid runoff) and reposition it periodically to get good distribution. A soaker hose if allowed is good method.
If the ground slopes severely, a root-watering needle may be necessary. Insert the needle no more than 6 inches into the ground and reposition it frequently since it moistens a small area around the insertion point.
It is important not to saturate the trunk area and you keep the top 8-12 inches of soil evenly moist throughout dry periods.
All watering must strictly comply with all City of Geneva water conservation regulations.


text:
New and Noteworthy, May 13th: This work is timeless
Posted by Chris Colgan on May 13, 2014
Weeks like this one are what make this column a joy for me to write. When there are so many high-quality albums debuting in a single week, I often don't know where to begin, because I'm so excited about it all. I certainly hope you all enjoy this list as much I do!
Down, Down IV – Part II (Down)
Well, apparently I lied back in 2012, when I said that Parts 2 through 4 of Down's fourth album would all be released in 2013. At least now Part 2 is done, and we will let you know as soon as word comes out about Parts 3 and 4. This EP will be the first recorded material from Down to not feature Kirk Windstein, who left the band last year to focus completely on Crowbar. If you want to hear what Down sounds like without Windstein, you can listen to the full stream of Part 2 right here.
Agalloch, The Serpent & The Sphere (Profound Lore)
It's hard to argue with the success of a band like Agalloch. On the one hand, both their previous album Marrow of the Spirit, and this one have been streamed by NPR, which is about as close to the mainstream as you can get without being on a top 40 station. On the other hand, all of Agalloch's albums since 2006's Ashes Against the Grain have appeared on almost every Top 10 list that I've seen for the years of their release. I guess that coverage from NPR doesn't exclude a band from being called "metal" anymore, which I take as a welcome sign of evolution in the genre.
Killer Be Killed, Killer Be Killed (Nuclear Blast)
How does a lineup like this one even get assembled? I mean, I've used the term "supergroup" many times before in situations like this, but I don't think that term properly describes Killer Be Killed. The lineup consists of Troy Sanders (Mastodon), Greg Puciato (The Dillinger Escape Plan), Dave Elitch (ex-The Mars Volta), and Max Cavalera (Soulfly/Cavalera Conspiracy/ex-Sepultura). The combined resume of these four performers would include some of the greatest material that has ever been released in the metal realm, and it defies the imagination to think of all four of them playing together. If you want to hear how it sounds when it all came together, check out the album stream that is live now.
Prong, Ruining Lives (Steamhammer/SPV)
Prong has been a powerful force in the metal scene for almost three decades now. 2012's Carved Into Stone was one of the best albums in the band's long and storied career, and Tommy Victor has delivered more of the same high-quality material on Ruining Lives. You can listen to the whole album on Spotify now, and you can also read our interview with Victor right here for insight into both this latest album and the band's history.
Mushroomhead, The Righteous & the Butterfly (Megaforce)
Mushroomhead is eight albums into their career, as of today. I never would have guessed that. Among the nu-metal bands that rose to prominence during the late '90s, only Korn has released more material than Mushroomhead, and Mushroomhead has certainly been the most consistent in their style. This album will be a landmark for the group, though, as it will be their first to feature three main vocalists. You can catch Mushroomhead on this summer's Mayhem Festival to see the three-singer performance on stage, as well.
Sworn Enemy, Living on Borrowed Time (Rock Ridge)
Sworn Enemy has changed a lot since the last time we saw them, 2009's Total World Domination. Aside from Sal Lococo, the band's lineup is totally different. However, the ethos of the band is still the same, and fully representative of the New York hardcore scene that they have been part of for their entire career. Loudwire has the entire album available to stream for your listening pleasure, and if you're going to the Black n' Blue Bowl this weekend, you'll get to see Sworn Enemy live.
Bane, Don't Wait Up (Equal Vision)
Bane's last release was 2005's The Note, an excellent album that cemented the Massachusetts hardcore band onto the scene. However, it's all coming to an end, as Don't Wait Up has been declared as Bane's final album. While the band still intends to play many shows before calling it quits for good, it's still sad to see such a talented group's career end. You can stream the whole album right now over at Alternative Press.
Hour of Penance, Regicide (Prosthetic)
The Italian metal scene has always been a bit underrated, escaping the radars of many people that pay more attention to the output from Germany and the Scandanavian region. Hour of Penance is one of many reasons why Italy deserves the metal world's attention. This technical death metal quartet has been active since 1999, and Regicide is their sixth album. Check them out if you like Origin, Decrepit Birth, or their countrymen Fleshgod Apocalypse.
Structures, Life Through a Window (Sumerian)
Canadian progressive group Structures is young and on the rise, with a fair amount of djent in their guitars and a lot of passion in their live show. The band was a hit during their run on last summer's version of The All Stars Tour, and they're poised to make some more big moves after the release of their sophomore LP. Life Through a Window is recommended if you like Volumes, Stray from the Path, Veil of Maya, or other modern progressive metal bands that are on the same rise.
Avatar, Hail the Apocalypse (eOne)
This Swedish band has dabbled in the melodic death metal that their country is known for, but recently they've become very successful playing hard rock and alternative metal. Touring with the likes of Avenged Sevenfold, Five Finger Death Punch, Lacuna Coil, and Sevendust in just the past year, Avatar is quickly gaining a foothold on the international scene. Hail the Apocalypse is the group's fifth full-length album.
Vallenfyre, Splinters (Century Media)
A supergroup formed in 2010, Vallenfyre features Paradise Lost guitarist Gregor Mackintosh and drumming legend Adrian Erlandsson in its lineup, among others. Mackintosh created the group after the death of his father in December 2009 due to lung cancer. Splinters is the sophomore effort from the group, and is recommended for fans of Demonical, Morbus Chron, and Vorum.
Glamour of the Kill, Savages (eOne)
Since releasing their debut full-length The Summoning back in 2011, Glamour of the Kill has managed a lot of high-profile touring. Fortunately, the UK-based post-hardcore group has been around since 2007, and they're no strangers to the road lifestyle. Savages expands on the style that the group has already displayed on their debut and the preceding EP's, which should make it a hit with fans of Escape the Fate, Blessthefall, and I See Stars.
Sylar, To Whom it May Concern (Razor & Tie)
This Queens-based five-piece has a lot of raw talent and a diverse skill set, allowing them to play with everyone from Born of Osiris to A Skylit Drive, along with anything in between. Recorded with producer Caleb Shomo of Beartooth, Sylar is on the cusp of a breakthrough in their scene. Recommended if you like Fit for a King or Buried in Verona.
Thine, The Dead City Blueprint (Peaceville)
Thine has been around for close to twenty years now, but they've been relatively obscured in their scene by heavyweights like Anathema and My Dying Bride. However, Thine is now ready to take it up a notch and deliver some powerful music that will make it impossible to ignore them any more. You can stream The Dead City Blueprint over at the A.V. Club for a taste of what's in store.
The Beards, The Beard Album (N/A)
Few things are more metal than having a great, hulking beard hanging off your chin. And although you may not have known it before, now you know – there is a band that wants to celebrate just that thing. The Beards are an Australian group that has done one thing over the course of their career – praise and glorify the wonders of the beard. If you want to experience the beard love for yourself, go check out the album stream at this location.
Next Week: A DVD from America's king of shock-horror leads off the list. Come see who it is next time on New & Noteworthy!
Tags: Agalloch, Avatar, Bane, Cavalera Cospiracy, Dave Elitch, Down, Glamour of the Kill, Greg Puciato, Hour Of Penance, killer be killed, Kirk Windstein, Mastodon, Max Cavalera, Mushroomhead, Prong, Sepultura, Soulfly, Structures, Sworn Enemy, Sylar, The Beards, The Dillinger Escape Plan, The Mars Volta, Thine, Troy Sanders, Vallenfyre
Categorised in: New & Noteworthy, New Music, News
Dave Elitch not in Antemasque anymore, either
The Beards to release another album about beards
← Meshuggah's guitarist worked on 'Wolfenstein' video game soundtrack
Beartooth have 'Beaten In Lips' with new video →


text:
Robert Saleh explains how K'Waun Williams impacts the whole 49ers defense
Photo courtesy of the San Francisco 49ers
Robert Saleh explains how K'Waun Williams impacts the whole 49ers defense
Dec 31, 2020 at 5:10 PM • --
Cornerback K'Waun Williams is one of many San Francisco 49ers players slated to hit free agency after this season. He has proven to be one of the best slot corners in the league and a vital part of defensive coordinator Robert Saleh's defense.
Saleh spoke with reporters on Thursday. He discussed Williams and how the cornerback's ability to quickly dissect what is happening on the field has a ripple effect on his teammates.
"The nickel position, in our scheme, we want our guys to go as fast as humanly possible," Saleh said. "The faster you go, the faster you clear it up for other people. So, with [Williams] and with all his preparation that he goes through and his instincts and understanding of football, when he makes a decision, there is no gray area in how he reacts. Because of it, it is very easy for players to play off one another. They feel color, they feel him going. He clears up the picture. It's when players are what we call floating that it just muddies up because you just can't feel where he is and what he's about to do.
"The reason why everyone loves [Williams] is, especially yours truly, the speed at which he operates and the instincts and the trigger — we call it trigger — and the way he triggers on game day. And within each play, it clears everything up for everybody."
Williams' savviness and quick decision making grant him some flexibility when it comes to what is expected of him.
"We allow [Williams] to do some things that are not in our playbook because we know he's going to go a hundred miles an hour and if he can, like I said, it clears it up," Saleh continued. "The nickel spot probably is one of the more important spots on our team, just because of the fact that it does, it clears up a lot of people. ... [Williams], when he's in there, because he is uniquely good at that nickel spot, he does clean it up for a lot of the guys."
Tarvarius Moore was asked how Williams' disruptiveness impacts his own play at the safety position.
"He definitely helps us out a lot when he's in the mix, down there in the box, just being disruptive, or shooting his shot in the gaps, and just cleaning up the run for us," Moore said. "What he does in coverage, gets hands on guys, rerouting them, making them go over the top, just clearing up the reads for us in the back end.
"He's phenomenal at what he does, so we always just show our appreciation to him and what he does each and every week."
49ers-Rams: Jimmy Garoppolo active; Trent Williams, K'Waun Williams among 6 inactives for Niners
The San Francisco 49ers have released the list of inactive players for their Week 18 matchup on the road against the Los Angeles Rams. These players will not suit up for Sunday's game. Inactives: LB Azeez Al-Shaair (knee) LB Marcell Harris (Achilles) DL Maurice Hurst (calf) CB K'Waun Williams T Trent Williams (elbow) DB Jarrod Wilson Quarterback Jimmy Garoppolo is active despite still dealing with a right thumb injury. He is expected to start against the Rams with rookie Trey Lance, last weekend's starter, slated to serve as his backup. On Friday, the 49ers listed Garoppolo as "questionable." Tackle Trent Williams, who did not practice this past week and was listed as
49ers' K'Waun Williams should be a go against the Cowboys
By Chris Beno
In case anyone missed it, the San Francisco 49ers starting slot corner K'Waun Williams opted out of the Week 18 matchup against the Los Angeles Rams because he still wasn't feeling quite right after being on the COVID/Reserve list earlier that week. NBC Sports Bay Area's Matt Maiocco appeared on KNBR Monday and brought up the fact that Williams was out. "K'waun Williams was on the COVID list, and he just didn't feel right, and he was cleared off the Covid list, so it wasn't that he was held out of the game because of Covid, but he just didn't feel right. Just the worry of the work that he wasn't able to put in heading into that game. So, he should be back." In his place the 49ers started veteran cornerback Dontae Johnson in the slot to cover wide
49ers-Cowboys: Kyle Shanahan provides updates on K'Waun Williams, Trenton Cannon
K'Waun Williams, one of the best slot corners in the league, came off the reserve/COVID-19 list on Saturday, the day before the San Francisco 49ers' regular-season finale against the Los Angeles Rams. He did not play in that game, though. A report from NBC Sports Bay Area indicated the cornerback wasn't feeling well enough to do so. Williams has not been listed on any practice participation reports this week, leading to the assumption that he has been a full participant and should play in Sunday's playoff game against the Dallas Cowboys. However, head coach Kyle Shanahan isn't revealing anything at this point. "K'Waun's one of the top nickels in the
Kyle Juszczyk explains 49ers' recent dominance over Rams
The San Francisco 49ers have not lost to the Los Angeles Rams since 2018. They have won five straight against the division rival and have a chance to make it six consecutive on Sunday. How has Kyle Shanahan's squad been so dominant against Sean McVay's in recent years? "I think we've just done a good job of playing to our strengths when we do play against them," fullback Kyle Juszczyk told NFL Network's Andrew Siciliano on Tuesday morning. "... Our strength is running the football, and controlling the time of possession, playing good defense, and taking the ball away. All that stuff is always easy to say, and every team wants to do that


text:
← A Troublesome Thing Happened in Yesterday's Market Selloff
These Two Charts Show the Shocking Truth Behind the Sanders/AOC Plan to Cap Credit Card Interest Rates →
By Pam Martens and Russ Martens: May 9, 2019 ~
Don McGahn With President Trump and First Lady Melania
Lawyers from Jones Day have been functioning like a Praetorian Guard around the president since the day he took office. How the firm landed so many of its partners into key positions in the Trump administration has baffled the media, especially since its partners were big supporters of Hillary Clinton's campaign. According to Bloomberg News, Jones Day's lawyers contributed $7,422 to Trump's campaign while showering Hillary Clinton's campaign with $267,899.
Wall Street On Parade has previously reported that Jones Day lawyers in Trump's White House Counsel office had previously represented Freedom Partners, the front group of Koch Industries, the giant fossil fuels company majority owned by the billionaire Koch brothers. Freedom Partners had quickly provided the Trump administration with a list of regulations it wanted gutted – like the Paris Climate accord (which Trump revoked on June 1, 2017) and numerous EPA rules. Jones Day had also been a lead law firm for Koch Industries' mergers and acquisitions for years. SourceWatch reported last year that a dozen people who previously worked at Freedom Partners were given jobs in the Trump administration. Among that group was Marc Short, former Freedom Partners President, who became Director of Legislative Affairs for Trump. Short stepped down in July of last year after many of his key objectives had been achieved.
On the same day that Donald Trump was sworn into office, the Jones Day law firm issued a press release indicating that 13 of its lawyers were heading to the Trump administration. Key among the posts were Don McGahn, who had been General Counsel to Trump's campaign committee, and was now going to be serving as White House Counsel. McGahn's Chief of Staff was also coming from Jones Day, Annie Donaldson. Both had previously represented Freedom Partners.
McGahn had another curious item on his resume, he had been the former Chairman of the Federal Election Commission, where he was credited with loosening regulations on campaign spending – an agenda that benefited men like the billionaire Koch brothers who have been setting up and funding front groups to meddle in elections for the past forty years.
Four Jones Day lawyers were heading to the Justice Department: Noel Francisco (Principal Deputy Solicitor General), John Gore (Deputy Assistant Attorney General, Civil Rights Division), Chad Readler (Principal Deputy Assistant Attorney General, Civil Division), and Michael Murray (Counsel to the Deputy Attorney General).
In addition to McGahn and Donaldson, surrounding the President from Jones Day was Bill McGinley (Deputy Assistant to the President and Cabinet Secretary), Greg Katsas (Deputy Counsel to the President), James Burnham (Senior Associate Counsel to the President), David Morrell (Associate Counsel to the President).
Other Jones Day appointments included: James Uthmeier (Special Advisor to the Secretary of Commerce), Stephen Vaden (Special Assistant to the Secretary of Agriculture) and Kaytlin Roholt (Special Counsel to the Senate Judiciary Committee.)
One name not included in the Jones Day press release who also moved to the White House on inauguration day was Michael Roman. Roman's primary salary was coming from Freedom Partners, but his financial disclosure form indicated that he had also received compensation "exceeding $5,000" from Jones Day for "research consulting" prior to moving to the White House.
Ken Vogel reported at Politico in 2015 that Roman headed a CIA-lite intelligence operation at Freedom Partners. Vogel writes:
"The competitive intelligence team has a staff of 25, including one former CIA analyst, and operates from one of the non-descript Koch network offices clustered near the Courthouse metro stop in suburban Arlington, Va. It has provided network officials with documents detailing confidential voter-mobilization plans by major Democrat-aligned groups. It also sends regular 'intelligence briefing' emails tracking the canvassing, phone-banking and voter-registration efforts of labor unions, environmental groups and their allies, according to documents reviewed by Politico and interviews with a half-dozen sources with knowledge of the group.
"The competitive intelligence team has gathered on-the-ground intelligence from liberal groups' canvassing events in an effort to assess the technology and techniques of field efforts to boost Democrats, according to the sources. And they say the team utilizes high-tech tactics to track the movements of liberal organizers, including culling geo-data embedded in their social media posts."
According to a subsequent report from Politico, Roman had worked directly under McGahn in the White House counsel's office. He left last year. Nancy Cook of Politico reported last year:
"As a former Koch operative and longtime opposition researcher, he cut a mysterious figure in the White House — as one of the few high-level non-lawyers working in the White House counsel's office. Few were certain of his exact job."
For what the Koch campaign machine has been up to lately, see our report Republican Candidates Are Paying a Fossil Fuels Conglomerate for Voter Data Mining.
Now, as Congressional subpoenas are flying at Deutsche Bank, Germany's largest bank with a large presence on Wall Street, and Trump is suing Deutsche Bank to prevent it from responding to the subpoenas – Jones Day is in a sticky wicket. Its former partners are advising the President but Deutsche Bank has been a long-term client of Jones Day.
As luck (or fortuitous planning) would have it, the Jones Day lawyers had received "a blanket waiver clearing them of ethical conflicts," and allowing them "to take up some matters they may have worked on in prior jobs," according to a report in the National Law Journal in May of 2017.
Last month the House Intelligence and the House Financial Services Committees subpoenaed documents from Deutsche Bank, President's Trump long time banker which has, over the years, loaned Trump "a total of well over $2 billion," according to the New York Times. During much of the time these loans were being made by Deutsche Bank, other banks refused to loan to Trump because of his history of defaulting and his businesses filing bankruptcy. That fact has raised the curiosity of these two House Committees because what Trump also has in common with Deutsche Bank is Russian money.
In 2017 Deutsche Bank settled with U.S. and U.K. authorities over a $10 billion Russian money laundering scheme, paying a combined fine of $630 million. In November of last year, Deutsche Bank's offices in Frankfurt, Germany were raided by 170 law enforcement officials. The probe involved potential money laundering.
We know what the Democrats, now in charge of House Committees since January, are thinking about when it comes to Trump and Deutsche Bank because of earlier reports. The draft report released by Democrats on the House Permanent Select Committee on Intelligence on March 13 of last year contained this paragraph:
"Donald Trump's finances historically have been opaque, but there have long been credible allegations as to the use of Trump properties to launder money by Russian oligarchs, criminals, and regime cronies. There also remain critical unanswered questions about the source of President Trump's personal and corporate financing. For example, Deutsche Bank, which was fined $630 million in 2017 over its involvement in a $10 billion Russian money-laundering scheme, consistently has been the source of financing for President Trump, his businesses, and his family. We have only begun to explore the relationship between President Trump and Deutsche Bank, and between the bank and Russia."
Deutsche Bank's "$10 billion Russian money-laundering scheme" which became known as "mirror trades," was the subject of a May 23, 2017 letter sent by Maxine Waters, then ranking member of the House Financial Services Committee and other House Democrats to John Cryan, then the CEO of Deutsche Bank. (Waters is now Chair of that Committee with the power to subpoena.) The letter began:
"We write seeking information relating to two internal reviews reportedly conducted by Deutsche Bank ('Bank'): one regarding its 2011 Russian mirror trading scandal and the other regarding its review of the personal accounts of President Donald Trump and his family members held at the Bank. What is troubling is that the Bank to our knowledge has thus far refused to disclose or publicly comment on the results of either of its internal reviews. As a result, there is no transparency regarding who participated in, or benefited from, the Russian mirror trading scheme that allowed $10 billion to flow out of Russia. Likewise, Congress remains in the dark on whether loans Deutsche Bank made to President Trump were guaranteed by the Russian Government or were in any way connected to Russia. It is critical that you provide this Committee with the information necessary to assess the scope, findings and conclusions of your internal reviews."
In February 2008, right in the midst of the financial crisis that would take down Wall Street in September of that year, Henry Klehm, the Global Head of Compliance for Deutsche Bank, joined Jones Day. He has been there ever since. Klehm had worked at Deutsche Bank from June 2002 to October 2007 when many of the instruments like Residential Mortgage Backed Securities (RMBS) and Credit Default Swaps (CDS) that blew up and deepened the financial crisis were created at Deutsche Bank.
For Deutsche Bank frauds which included the period when Klehm was there, the U.S. Justice Department fined the bank $7.2 billion in January of 2017. Part of the charges, which Deutsche Bank admitted to, were these:
"Deutsche Bank knowingly and intentionally securitized loans originated based on unsupported and fraudulent appraisals. Deutsche Bank knew that mortgage originators were 'giving appraisers the value they want[ed]' and expecting the resulting appraisals to meet the originators' desired value, regardless of the actual value of the property. Deutsche Bank concealed its knowledge of pervasive and consistent appraisal fraud, instead representing to investors home valuation metrics based on appraisals it knew to be fraudulent. Deutsche Bank misrepresented to investors the value of the properties securing the loans securitized in its RMBS and concealed from investors that it knew that the value of the properties securing the loans was far below the value reflected by the originator's appraisal.
"By May 2007, Deutsche Bank knew that there was an increasing trend of overvalued properties being sold to Deutsche Bank for securitization. As one employee noted, 'We are finding ourselves going back quite often and clearing large numbers of loans [with inflated appraisals] to bring down the deletion percentages.' Deutsche Bank nonetheless purchased and securitized such loans because it received favorable prices on the fraudulent loans. Ultimately, Deutsche Bank enriched itself by paying reduced prices for risky loans while representing to investors valuation metrics based on appraisals the Bank knew to be inflated."
A key area where Jones Day has provided repeated legal representation to Deutsche Bank has been in the Credit Default Swap area.
Some of the Jones Day lawyers who took their seats in the Trump administration on inauguration day are no longer there. In less than a year's time, Gregory Katsas went from Jones Day to the Trump administration and was then nominated by Trump and confirmed as a Federal Judge on the U.S. Court of Appeals for the D.C. Circuit. Jones Day partner Chad Readler was confirmed in a highly controversial vote of 52-47 in March of this year to sit as a Federal Judge on the 6th U.S. Circuit Court of Appeals. Federal Judges, once confirmed, have a lifetime appointment to the bench.
Don McGahn has returned Jones Day where he is listed as "Practice Leader Government Regulation." He is not enjoying a quiet return to corporate law practice, however. The House Judiciary Committee has issued a subpoena to him for documents related to Trump's potential obstruction of justice in Bob Mueller's Special Counsel probe. According to Politico's reporting this week, McGahn is defying the subpoena, raising the risk that he may be held in contempt of Congress.
If there is any hope for America to restore itself to a true democracy, the House must continue to take this investigation where the facts lead – including the outsized influence that the Jones Day law firm has had in the Trump administration and its ties, and the President's ties, to Deutsche Bank. Another key area for investigation are the Jones Day ties to the Koch's Freedom Partners and the role that group has played in dismantling critical regulations and safeguards that protect the American people.


forecasting of physical and biogeochemical processes in regional seas and between continental slope and coast. Research methods include data analysis, numerical modelling and data assimilation. Major interest is given to circulation and thermodynamics, as well as ecosystem and sediment dynamics. Improving model skills by maximising the use of available data leads to improving forecasts and state estimates, which presents an important scientific contribution in the field of decision making and society in general.


text:
TRIAL STARTS SOON: Francisco "Chavo" Romero facing charges for 2013 protest vs. Oxnard Police killings
Francisco Romero speaks at Oxnard Police Department during anti-brutality march October 12, 2014 (credit: Agatha Muñoz)
from Raza Press and Media Association
UPDATE – ALERT! TRIAL POSTPONED: Due to court unavailability, Trial for the Romero vs. OPD case has been postponed, tentatively set for May 20th. We will send out details. In the next few days, we will also initiate an email and phone call campaign to demand the District Attorney to Drop the Charges! This way both local supporters as well as those further out can participate in keeping up the pressure! An attack on one, is an attack on all! La lucha sigue!
Trial begins this Friday May 8th, 8:30am, Dept. 23. Ventura County Courthouse located at 800 S. Victoria Avenue, in Ventura, Ca.
Over one year and a half ago, the City of Oxnard, and the Oxnard Police Department (OPD) – in the most cowardly and shameless attempts to silence and intimidate the local community protests against police brutality, issued five whack-lame "traffic" citations against Francisco "Chavo" Romero. El Chavo has been an outspoken critic of local Oxnard Police brutality for nearly 20 years .
On October 2013, Chavo, along with nearly 250 protestors marched for the one year commemoration of the slaying of Alfonso Limon, a young man that was shot down, as he kneeled with this hands up, by the Oxnard Police Department.
JOIN US! This Friday, trial begins, after a one-year-and-half battle and attempt to dismiss under discriminatory prosecution was denied, by a white judge, in a racist conservative court, denied the motion to dismiss, under the pretext that Chavo was the only "identifiable" protestor out 250+ marchers that they decided to prosecute. Now, the District Attorney won't back down – and will attempt to make an example of Chavo and those that attempt to fathom the possibility of having the right to resist and dissent.
EL PUEBLO RESISTE! Despite the excuse that Chavo was the only "identifiable" protestor, since then, at least two mass marches have taken place, where the community, righteously and courageously has taken the protests to the streets, and have denied succumbing to the city-police-county efforts of repression.
The latest march, held on April 11th, in memory of Megan Hockaday – a young black woman killed in front of her children by the Oxnard Police Department, is a testament of the local community's defiant and bold call of taking protests to the streets and claiming "No Justice, No Peace – Killer Cops Off our Streets!"
The city, the cops, and the district attorney, will attempt to criminalize our gente, especially vocal critics and activists – but, everyday – our community has lost its fear to fight back and resist!
LA LUCHA SIGUE!
This entry was posted in Brutalidad Policial // Police Brutality, En Las Noticias // Media Coverage, Notas de prensa // Press releases. Bookmark the permalink.
"Shooting Tattoos" Investigation of Oxnard Police Nearly Complete; Grant for Body Cameras Submitted
April 28, 2015 Meagan Hockaday vigil photos & Oxnard City Council video
One thought on "TRIAL STARTS SOON: Francisco "Chavo" Romero facing charges for 2013 protest vs. Oxnard Police killings"
Culture Shift says:
Case needs to be dropped. Romero is a community leader to be treated with fairness and respect. His criticism of unwarranted violence by police officers is correct. It's clearly a problem that requires serious, systematic, in-depth, transformative action by the City and the Chief of Police. The courts should support all calls and efforts for reform.


text:
USD Professor of Finance Cited in Financial Times
Wednesday, December 4, 2019TOPICS: Faculty and Staff
University of San Diego Assistant Professor of Finance William Beggs
begin quoteProfessor William Beggs says that the use of in-house funds as underlying investments can compromise performance, pointing out that target-funds providers who fill their target-date funds with their own investment strategies have little incentive...
William Beggs, assistant professor of finance, was cited in the Financial Times for his insight on how conflicts of interest in the management of retirement assets negatively impacts financial portfolio performance.
Conflicts of Interest in Target-Date Funds Catch SEC's Eye
From lawsuits for high fees to regulatory probes into the way funds are sold, the US asset management industry has been attacked on multiple fronts in recent years.
But one area that has largely escaped unscathed up until now is the $1.7tn target-date fund market, which has experienced runaway growth and is a central plank of the US defined contribution retirement system.
Target-date funds — retirement portfolios that rebalance automatically according to the investor's age and target retirement date — account for almost a third of assets held in US employee retirement plans, according to Callan Associates, a consultancy.
Yet critics fear target-date funds could be an accident waiting to happen, warning that concentration and competition issues are putting investors at risk.
"Target-date funds have very much been under the radar," says Chris Brown, founder and principal of Sway Research, a consultancy focused on fund distribution within 401(k) plans. "This has allowed the big captive providers to get bigger and bigger."
The target-date market is controlled by a small number of asset managers. The top three providers — Vanguard, Fidelity Investments and T Rowe Price — manage 63 per cent of the total asset pool, according to Sway Research. In addition, the vast majority of target-date managers exclusively invest in their own in-house funds, with just one provider in the top 10 — Principal — outsourcing the portfolios to external managers.
One reason for the closed nature of the market is downward pressure on management fees. The average fee for target-date funds fell to an all-time low of 0.62 per cent in 2018, down from 1.03 per cent in 2009, according to Morningstar. The squeeze has forced target-date providers to prioritise in-house funds over external managers to save money.
"Ten years ago if you had a well-constructed 'best of breed' multi-manager fund, you had an advantage," says Jim McCaughan, former chief executive of Principal Global Investors. "Now that's less the case because of the intense focus on price."
The conflicts of interest inherent in this model are rising up the US Securities and Exchange Commission's agenda. The agency's compliance inspections and examinations unit this month issued a rare warning following a one-off review of target-date funds, criticising managers for failing to properly disclose conflicts resulting from the use of in-house funds.
This issue has taken on particular urgency given the increasing proportion of US workers being channelled into target-date funds as default investment choices. Since the landmark Pension Protection Act was introduced in 2006, US employees are automatically enrolled in 401(k) plans if they are available. The rise of target-date funds was sparked by the change of legislation, as the products responded to a need for default investment options.
"The stamp of approval that came with the Pension Protection Act really opened the floodgates for target-date funds," says Jeff Holt, director of multi-asset and alternative strategies for Morningstar.
Morningstar's research shows that target-date funds have more than quintupled their assets under management over the past decade, during which they have regularly recorded double-digit annual growth. "The fact that so many retirement investors are relying on them is what has brought them to the SEC's attention," says Mr Holt.
Investors' hands-off approach to target-date funds — designed as simple, "set it and forget it" investments — gives specific impetus to investor protection concerns.
"The assumption is that those investors don't dig into portfolios or look at what they are invested in," says Mr Holt. "Because of that it is much more important that investors aren't misled as to what they're getting."
Chief among the questions regulators will be asking about target-date funds is whether they deliver good investor outcomes. William Beggs, assistant professor of finance at the University of San Diego School of Business, says that the use of in-house funds as underlying investments can compromise performance, pointing out that target-funds providers who fill their target-date funds with their own investment strategies have little incentive to fire the underlying manager if returns tail off.
Research by Mr Beggs found that the presence of conflicts of interest in the management of retirement assets materially impacts performance. Target-date funds run by managers who also provide investment consulting services to 401(k) plans underperformed conflict-free funds by 40 to 50 basis points per year.
In recent years, financial services groups such as Prudential, American Century, BlackRock, Goldman Sachs and Putnam Investments have been hit by lawsuits from employees over...


No other injuries were reported, though the man had pointed the gun at two people in the house who were led out by police before the shootout.
A 107-YEAR-old Arkansas man was killed during a shootout with US police and SWAT team members, local authorities said.
Police were responding to a disturbance at a house in Pine Bluff city Saturday afternoon and determined that suspect Monroe Isadore had pointed a gun at two people, according to a statement given to local media.
The two victims were led out of the house. As the officers approached the bedroom where Isadore had taken cover, he shot through the door.
Isadore failed to injure any of the officers with his gunfire. Supervisors began negotiating with Isadore and a Special Weapons and Tactics team was called out.
Using a camera inserted into the room, the SWAT team was able to confirm that Isadore was armed with a handgun. The officers then slipped gas into the room before Isadore responded with gunfire.
"Shortly afterwards, a SWAT entry team inside the residence breached the door to the bedroom and threw a distraction device into the bedroom," the Pine Bluff Police Department statement read.
The statement did not say which type of distraction device was used.
Law enforcement officials are investigating the incident.
Email "107-year-old man killed in shootout with US police".
Feedback on "107-year-old man killed in shootout with US police".


text:
ACC 2022 Late-breaker Discussion: The SODIUM-HF Trial
View Transcript Download Transcript
In this in-depth conversational interview, Late-breaker host Dr Harriette Van Spall (McMaster University, CA) meets PI, Dr Justin A. Ezekowitz (University of Alberta, CA) to discuss the SODIUM-HF trial (CT02012179). The aim of the trial was to evaluate the effects of a low-sodium diet, compared to usual care in patients with heart failure.
Presented first at ACC.22, the trial showed that reducing sodium intake did not reduce clinical events but there was a modest benefit on quality of life as measured by the KCCQ, and in NYHA class.
Recorded remotely from Edmonton and Hamilton, 2022.
- I'm Harriette Van Spall, associate professor of medicine, cardiologist and researcher at McMaster University in Canada and it is my absolute delight to invite my friend, Justin Ezekowitz, professor of medicine in the division of cardiology at University of Alberta, who is here at ACC 2022 to present his late breaking clinical trial the SODIUM-HF trial. Welcome Justin.
- Thank you, Harriette and great to be here.
- I'm so delighted to talk to you about this trial because it is rich with clinical implications that will inform the care of our patients. You and I both take care of patients with heart failure and sodium restriction has become the default order on many of our in-patient order sets. It is something we also advise patients to do to self manage their heart failure care and so your trial is particularly important. Tell us why you conducted it and what the research question was that you aimed to answer.
- So thanks Harriette and so one of the things that as you as a practitioner, you know, heart failure clinic and and myself as well is you realise you make recommendations, a lot of things around medications and devices and self-care every day and one of the things that I was struck by was that we make this recommendation, you know eat less salt and it comes out in a variety of different ways, but that's generally what it means and, you know, I started looking at why do we make this recommendation? And we're using high dose diuretics, We're doing all these other fancy things but we just don't have a good scientific rationale to do so. So I started to look at this area with my colleagues and we said, well why don't we actually look at the scientific, the clinical trials, a higher quality evidence and realised that there's really a lack of good high quality evidence from which we could support our recommendation which of course led to the design of a small protocol which led to a larger clinical trial design And we of course then set out, you know what are our real objectives? And so we decided we wanted to really tackle this area and say, does reducing the dietary sodium improve or reduce the number of clinical events? So really is it, can we link the diet to the clinical event? And that was a really fundamental difference from just saying, hey, can we measure sodium in the diet? That was a big difference from the prior clinical trials where that was really the fundamental thing they were doing.
- Right, And so yours was a multicenter clinical trial in ambulatory patients with chronic heart failure and your primary composite endpoint encompassed clinically relevant outcomes of all cause mortality, cardiovascular hospitalizations and emergency department visits. Tell us a little bit about the trial design and how you facilitated appearance to your intervention which is a tough intervention for many.
- Absolutely, and the intervention itself which, so patients were randomised one-to-one to the intervention or usual care. Now, usual care, first of all is really just following any general recommendations given by any clinician around any dietary modification of sodium which for most patients meant that they have a dietary sodium content of around anywhere from 2,500 milligrammes per day or or sometimes greater, sometimes lower. We did exclude people who are already eating an exceedingly low dietary sodium of less than 1,500 milligrammes a day. Once patients were randomised, the intervention was really centred around a behavioural intervention which is what nutrition is. We all eat food and we all have to think about how we shop for and eat our food. We looked at different designs. We thought about the Dash Diet which was, you know meals that are fed to people made by a metabolic kitchen. We knew that that was not either pragmatic or or even feasible in a larger scale. So we took upon a menu based system where patients were given menus based on their caloric intake, their requirements, and just, we substituted out at higher sodium things for lower sodium things and so they could select off the menu whatever they wanted and it turns out there's a lot of good variety in there. We further adapted this to really the six countries that were involved, Canada, Chile, Columbia, Mexico, Australian, New Zealand. We adapted those menus because we all eat locally and just then tracked it by food records to see what their dietary sodium intake was. The three day food records are quite valuable because then a dietician could both counsel, like could assess and counsel based on that information.
- Right, so was this diet directed by a nutritional scientist? How did you devise these menus?
- Yeah, so we had a really smart set of dieticians that form the dieticians working group and they were from around the world that were part of the clinical trial and they helped to shape the the menus and how they were designed. So they were, you know, balanced and appropriate and all those usual things that we get from our dietary colleagues. Now, once we designed the menus, I'm not a dietician. So, you know, I don't have the expertise from which to design that, we had to think about how they would be deployed and from a very pragmatic approach, we looked at the clinical trial sites, you know the 26 clinical trial sites from around the world and for sites that had a dietician, it was pretty straightforward, for sites, we had some nurses, nurse practitioners even some physicians giving this advice after they went through appropriate training to make sure they were skilled to do so and really we found that the menus were widely accepted by patients as a generally easy to do type of activity. It was much easier than following a Dash Diet type of approach where they got their meals which would not be very feasible if they're going out or eating with family or friends. So they, you know, they were making a dietary modification but also a behavioural intervention at the same time.
- Right, certainly in observational data sets there are concerns that diets low in sodium may also be low in some of the micronutrients. Did you sort of design the the diets around micronutrients as well or was it strict sodium restriction? And the second part is how did you determine what that sodium level was going to be?
- Yeah, so two really good questions. The first is, we chose to only modify the dietary sodium. So the diets were balanced and we didn't want to modify anything else because we really wanted to solely test dietary sodium without changing micronutrients. Now, of course, anytime you change a diet, you naturally are changing those things. So we'll have plenty of data from the three day food records which are followed serially every three months, so for which we can digest those micronutrient changes that may have occurred. So we will have to do then second explorations of our data. We just haven't yet got to that. We did also track things like fluid intake which I think people would naturally think might be a link and really there's no difference in fluid intake for each group. In terms of how we track it, we chose not to track urinary sodiums which is one method that's being used in other projects. There's two really good rationales of why not to do that. Most of our patients were on a diuretic, and urinary sodiums have been tested by our colleagues of Toronto, looking at patients with heart failure. They actually don't track what they eat very well or dietary sodium. So it wouldn't it been a great marker. The second is it becomes very impractical because urinary sodiums, tracking urinary sodiums requires spot urinary sodiums reflected to a 24-hour urinary sodium. It's just not very feasible in a large clinical trial setting. So we chose the food records and after all, that is what patients were recording their eating, so that is a thing we're trying to change and better to measure.
- Okay, so you randomised patients to 1,500 milligrammes of a sodium restricted diet versus a usual diet and tell us how long you followed up the patients for and what you found.
- Yeah, so the primary endpoint was 12 months. We have an ongoing longer term follow up going but the primary endpoint is at 12 months, overall, we looked at our primary endpoint and found a couple of key things. First of all, did we lower sodium enough? We lowered sodium by about 415 milligrammes per day by 12 months. So it was met by about six months and 12 months was about the same. So we were able to get close to what we wanted which was around 500 milligrammes of sodium lowering or difference between the groups. We didn't have any weight changes, blood pressure changes or energy intake, you know, caloric intake changes. So we were very well balanced in terms of just lowering sodium as much as we can assess it, in terms of the primary outcome, we did not see a statistically significant difference in the primary outcome. Hazard ratio was 0.89. This was not statistically significant between the two groups. There is a hint or an indication that the lower sodium group may have had a slightly better outcome where we looked at our individual outcomes such as cardiovascular related hospitalizations but there was no statistically difference, significant difference across any of the three components that made our primary outcome. So we have to conclude based on the purist view of that there was no significant difference on the primary outcome by lowering dietary sodium.
- So very important findings. How do you think that these are going to translate to clinical care? How do you perceive the guidelines are going to adopt the findings of your trial and recommendations that they make?
- Yeah, so this is a really key question that's been on my mind as a former guidelines chair is how would I integrate this into the overall recommendations. Now there's a couple of other tidbits that may influence that, the first is we tracked two other or three other things that I think may influence the guideline or a clinician or a patient to decide what they might want to do. The first is we had a small indication that there was an improvement in a six minute walk test and that may indicate that there's a functional gain by a lower sodium diet, but it was not significant. However, the quality of life scores were actually clinically and clinically meaningfully different on a lower sodium diet, as in they got a better quality of life being on a lower sodium diet over the six and 12 months. Similarly, the NYHA classes were also better on a lower sodium diet compared to the usual care. So when you ask, you know, how do we integrate this? We have, you know, no difference on the clinical endpoints but we do have an important one on the quality of life as well as NYHA classes. So as a clinician, I might say this may be part of a strategy to improve overall care of a patient. From a patient perspective, it might be seen as something as they can drive as their own self care and from a guidelines committee, you know this is going to be a tricky wicket, is if we are only focusing on the overall clinical outcomes which is what we generally focus in on versus secondary outcomes, which may indicate that it's generally better to be on a lower sodium diet and I think that's where people will have to have a lot of discussion and debate as to what the relative value is of our trial compared to the prior literature.
- Right, and were your secondary endpoints adjusted for multiplicity?
- Yeah, so we've done a number of secondary looks at this at how we do this. We've done multiplicity, we've done some co-variant adjustment and in fact, we've done a number of different factors, which really, I think we will find are, they're robust, the secondary outcomes, but I do think that's where people have to kind ultimately read the manuscript, digest the information and then as we work through secondary analysis of our dataset, I think that's where a lot of the information that might further influence what we decide to do a year or two years from now as we kind of go through that longer process of trying to figure out more of the information from our data.
- Yeah, and I agree, health status, health related quality of life are such important endpoints that we underemphasize in so many of our regulatory approvals processes. Although it's starting to change at FDA. I wonder if you would tell us a little bit more about how you measured health related quality of life and whether the differences were beyond the minimally clinically important difference thresholds.
- Yes, so we measured, we used KCCQ and we chose chose this because it's well validated and it's been kind of our general go-to for a quality of life, disease specific quality of life assessment. We measured it at baseline six and 12 months and so we have, once we adjust for the baseline differences, we have an adjusted mean difference in the overall summary score of 3.66, sorry, 3.38 and that is very similar to our large clinical trials. In fact, it may even be greater in the difference between the two groups once you account for the baseline variation. So, very similar to that of our larger scale trials. When we looked at the physical limitation score, also an interesting one for me 'cause of the six minute walk differences, we had a difference about 3.77. So you put that together as to what the differences between the groups are. That's quite important because overall our differences in the quality of life from baseline are about five or six points. So that's like very similar to the overall difference and then the difference between the groups is in the three to four range and those generally are meant to be clinically important differences. We're always striving for the five, but very rarely seen in even our larger clinical trials.
- Right, and another question that comes up is whether the patients knew, were they unblinded to the intervention? So did the patients know that they were on sodium restricted diet or not?
- Yeah, absolutely. This was an unblinded to patients 'cause we looked at many different ways to try to blind this and there just weren't any feasible ones from the patient level. So that influences any of the things such as a quality of life assessment, six minute walk test, you can imagine even the NYHA class, even though we blinded the outcome assessors, is when they were gathering the KCCQ data or assessing the NYHA class or doing the six minute walk test, the patient did know what diet they were eating. There's just no way to really blind that effectively. They could have known that very easily even if we had not informed them. They would've kind of realised when we took out capers and all the salty good stuff, they would've realised very quickly which one they're on.
- Right, well, I think your trial is super exciting and really transforms the way we counsel patients about sodium restriction. It's almost become a mantra that previously was informed a very modest quality evidence and you've really shown us not only the lack of clinical benefit in sodium restriction but the possibility of improving patient reported measures and so balancing the findings from your primary analysis with your secondary endpoints but also how a well executed trial can answer a question in a manner that changes the way we deliver care even when it is something that's dietary based which often takes a back seat to some of the drug and device interventions that we tend to focus on and celebrate. I celebrate your findings. I'm so proud of you as a colleague, congratulations on being here at ACC and on yet another important trial that you've led. Thank you for spending your time with us, Justin.
- Oh, thank you, Harriette and thanks for the interest in the trial and also being such a good colleague. So my appreciation to you.
- My pleasure.
Ranolazine to Improve Diastolic Performance
Desak Ketut Sekar Cempaka Putri , Andrianto Andrianto , Makhyan Jibril Al-Farabi , et al
LVAD: A Bridge to A Brighter Future
Sern Lim,
Watch time: 4m 18s
Obstructive Hypertrophic Cardiomyopathy
Marc Dweck, Milind Y Desai, Carolyn Ho, et al
Watch time: 1h 28m 56s (4 videos)
Personalising Your Approach to Heart Failure Treatment
Biykem Bozkurt, Giuseppe Rosano,
Watch time: 13m 13s (2 videos)
e-SPACE CRM 2023 – Day Two
Stefan Anker, Javed Butler, Antonio Ceriello, et al